1)Brilla CG, Matsubara LS, Weber KT:Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 25:563-575, 1993
2)Chapman AB, Johnson A, Gabow PA, Schrier RW:The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease, N Engl J Med 323:1091-1096, 1990
3)Gockel I, Heintz A, Kentner R, Werner C, Junginger T:Changing pattern of the intraoperative blood pressure during endoscopic adrenalectomy in patients with Conn's syndrome. Surg Endosc 19:1491-1497, 2005
4)河邊博史,猿田享男:腺腫による原発性アルドステロン症 最近の話題.ホと臨床44:781-788, 1996
5)Litchfield WR, Anderson BF, Weiss RF, Lifton RP, Dluhy RG:Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31:445-450, 1998
6)宮城徹三郎,石浦嘉之,小林忠博,島村正喜,内山伸治:脳血管障害後に発見された原発性アルドステロン症.臨泌46:847-850, 1992
7)Morita A, Fujiwara S, Hayashi K, Ohtsu H, Kirino T:Risk of rupture associated with intact cerebral aneurysms in the Japanese population:a systematic review of the literature from Japan. J Neurosurg 102:601-606, 2005
8)中川敦博,蘇 慶展,斉藤桂一,山下洋二,白根礼造,吉本高志:高血圧性脳内出血で発症した原発性アルドステロン症の1例.No Shinkei Geka 29:973-977, 2001
9)Nakamura Y, Suzuki S, Suzuki T, Ono K, Miura I, Satoh F, Moriya T, Saito H, Yamada S, Ito S, Sasano H:MDM2:a novel mineralocorticoid-responsive gene involved in aldosterone-induced human vascular structural remodeling. Am J Pathol 169:362-371, 2006
10)Nishimura M, Uzu T, Kuroda S, Nakamura S, Inenaga T, Kimura G:Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 33:261-266, 1999
11)Schievink WI:Intracranial Aneurysms. N Engl J Med 336:28-40, 1997
12)Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T:Vascular complications in patients with aldosterone producing adenoma in Japan. comparative study with essential hypertension. J Endocrinol Invest 18:370-373, 1995
13)吉本貴宣,平田結喜緒:心血管障害におけるアルドステロンの病態生理学的意義.血管29:47-55, 2006